A detailed history of Lazard Asset Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,783 shares of NVCR stock, worth $62,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,783
Previous 19 19810.53%
Holding current value
$62,343
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.61 - $23.34 $58,756 - $87,851
3,764 Added 19810.53%
3,783 $59,000
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $41,377 - $84,737
-1,027 Reduced 98.18%
19 $0
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $70,573 - $92,973
1,038 Added 12975.0%
1,046 $79,000
Q2 2022

Aug 09, 2022

SELL
$56.6 - $89.9 $75,957 - $120,645
-1,342 Reduced 99.41%
8 $0
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $50,706 - $71,250
843 Added 166.27%
1,350 $111,000
Q4 2021

Feb 09, 2022

SELL
$75.08 - $121.99 $1.1 Million - $1.79 Million
-14,659 Reduced 96.66%
507 $38,000
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $1.68 Million - $2.81 Million
14,440 Added 1988.98%
15,166 $1.76 Million
Q2 2021

Aug 12, 2021

SELL
$130.4 - $225.58 $14,604 - $25,264
-112 Reduced 13.37%
726 $161,000
Q1 2021

May 14, 2021

SELL
$124.11 - $190.17 $16,382 - $25,102
-132 Reduced 13.61%
838 $110,000
Q4 2020

Feb 11, 2021

SELL
$112.16 - $174.14 $98,364 - $152,720
-877 Reduced 47.48%
970 $167,000
Q3 2020

Nov 13, 2020

SELL
$58.05 - $111.31 $18,750 - $35,953
-323 Reduced 14.88%
1,847 $205,000
Q2 2020

Aug 13, 2020

SELL
$57.2 - $74.41 $28,714 - $37,353
-502 Reduced 18.79%
2,170 $128,000
Q1 2020

May 14, 2020

BUY
$57.05 - $95.75 $118,606 - $199,064
2,079 Added 350.59%
2,672 $179,000
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $36,682 - $57,995
593 New
593 $44,000
Q1 2018

May 14, 2018

SELL
$19.3 - $23.65 $259,102 - $317,501
-13,425 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$16.3 - $21.9 $218,827 - $294,007
13,425
13,425 $271,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.73B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.